Monte Rosa Therapeutic (NasdaqGS:GLUE) FY Conference December 02, 2025 01:30 PM ET Company ParticipantsMarkus Warmuth - CEOConference Call ParticipantsTed Tenthoff - Senior Biotech AnalystTed TenthoffGreat. Good afternoon, everyone. My name is Ted Tenthoff. I'm a senior biotech analyst at Piper Sandler. And before I begin, I'm required to point out certain disclosures regarding the relationship between our next presenting company, Monte Rosa, and Piper, which are listed at the back of the room and also at t ...